Tissue Repair Ltd Announces New Security Issue
Tissue Repair Ltd: Advancing Trials and Boosting Sales
Tissue Repair Ltd Issues New Employee Options
Tissue Repair Secures Third US Patent for Glucoprime Compound
Tissue Repair (ASX:TRP) secured a third US patent for its Glucoprime compound. Glucoprime and its variants form the underlying technology platform behind Tissue Repair's lead drug candidate TR987 for
Tissue Repair's (ASX:TRP) Wound Healing Drug Cleared by FDA
No Data